SD Biosensor Past Earnings Performance
Past criteria checks 1/6
SD Biosensor's earnings have been declining at an average annual rate of -56.9%, while the Medical Equipment industry saw earnings growing at 17.1% annually. Revenues have been declining at an average rate of 65.4% per year. SD Biosensor's return on equity is 6.2%, and it has net margins of 26.8%.
Key information
-56.91%
Earnings growth rate
-58.42%
EPS growth rate
Medical Equipment Industry Growth | 22.66% |
Revenue growth rate | -65.39% |
Return on equity | 6.18% |
Net Margin | 26.76% |
Last Earnings Update | 30 Jun 2025 |
Recent past performance updates
Recent updates
SD Biosensor's (KRX:137310) Strong Earnings Are Of Good Quality
Aug 20Here's Why SD Biosensor (KRX:137310) Can Afford Some Debt
Jul 02There's Reason For Concern Over SD Biosensor, Inc's (KRX:137310) Massive 30% Price Jump
May 27Is SD Biosensor (KRX:137310) Weighed On By Its Debt Load?
Jan 07Revenues Not Telling The Story For SD Biosensor, Inc (KRX:137310) After Shares Rise 29%
Dec 02What SD Biosensor, Inc's (KRX:137310) 25% Share Price Gain Is Not Telling You
Aug 24Would SD Biosensor (KRX:137310) Be Better Off With Less Debt?
Aug 08Insufficient Growth At SD Biosensor, Inc (KRX:137310) Hampers Share Price
Jul 03Insufficient Growth At SD Biosensor, Inc (KRX:137310) Hampers Share Price
Feb 28Revenue & Expenses Breakdown
How SD Biosensor makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 25 | 702,551 | 188,000 | 218,521 | 80,981 |
31 Mar 25 | 703,510 | -105,936 | 211,057 | 85,893 |
31 Dec 24 | 694,574 | -98,411 | 201,982 | 87,946 |
30 Sep 24 | 674,066 | -63,218 | 202,423 | 78,600 |
30 Jun 24 | 654,489 | -192,401 | 196,915 | 75,528 |
31 Mar 24 | 649,665 | -256,179 | 221,860 | 68,928 |
31 Dec 23 | 655,677 | -467,712 | 210,868 | 64,203 |
30 Sep 23 | 693,451 | -693,729 | 194,538 | 62,952 |
30 Jun 23 | 1,093,588 | -208,280 | 197,286 | 56,685 |
31 Mar 23 | 1,725,958 | 214,230 | 177,044 | 53,111 |
31 Dec 22 | 2,932,001 | 911,362 | 178,817 | 45,762 |
30 Sep 22 | 3,178,373 | 1,344,936 | 194,307 | 34,941 |
30 Jun 22 | 3,153,907 | 1,175,426 | 208,498 | 29,575 |
31 Mar 22 | 3,139,288 | 1,122,436 | 194,183 | 23,561 |
31 Dec 21 | 2,929,961 | 1,088,471 | 178,973 | 19,086 |
30 Sep 21 | 3,417,145 | 1,294,930 | 161,278 | 19,838 |
30 Jun 21 | 3,426,350 | 1,269,537 | 159,758 | 17,096 |
31 Mar 21 | 2,755,620 | 1,019,313 | 127,965 | 11,835 |
31 Dec 20 | 1,686,163 | 615,636 | 104,736 | 10,388 |
31 Dec 19 | 72,962 | 3,153 | 13,130 | 4,869 |
Quality Earnings: A137310 has a large one-off loss of ₩140.6B impacting its last 12 months of financial results to 30th June, 2025.
Growing Profit Margin: A137310 became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A137310's earnings have declined by 56.9% per year over the past 5 years.
Accelerating Growth: A137310 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: A137310 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-3.6%).
Return on Equity
High ROE: A137310's Return on Equity (6.2%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/10/13 07:41 |
End of Day Share Price | 2025/10/13 00:00 |
Earnings | 2025/06/30 |
Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
SD Biosensor, Inc is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Jonghyun Park | DAOL Investment & Securities Co., Ltd. |
Jaehee Won | Shinhan Investment Corp. |